GET THE APP

General overview of the comet assay | 31003
Journal of Cell Science & Therapy

Journal of Cell Science & Therapy
Open Access

ISSN: 2157-7013

+44 1300 500008

General overview of the comet assay


6th World Congress on Cell & Stem Cell Research

February 29-March 02, 2016 Philadelphia, USA

Diana Anderson

University of Bradford, UK

Keynote: J Cell Sci Ther

Abstract :

The comet assay is an important toxicological method for measuring DNA strand breaks in single cells. Cells embedded in agarose on a microscope slide are lysed with detergent and high salt. Electrophoresis at high pH results in structures resembling comets, observed by fluorescence microscopy. The comet tail is formed by DNA fragments moving towards the anode. The assay can be used for genotoxicity testing of novel compounds and exotoxins, human bio-monitoring, molecular epidemiology, basic research into DNA damage and repair and effects of nanoparticles. DNA repair can be measured after treatment of cells with a DNA damaging (challenging) agent and measuring damage remaining after different time intervals or with repair enzymes. This overview will be illustrated with examples from the work of the author��?s group and collaborators. These will include studies for genotoxicity testing of various agents for exotoxins the work with DBP halogenated acetic acids for human biomonitoring and molecular epidemiology the work with mother and babies, diabetes and lead exposed children and for fundamental research that with drug resistant non-Hodgkin��?s lymphoma patients over-expressing p53 mutant protein and lacking DNA repair. Most of this work has been carried out in somatic human lymphocytes but it can also be carried out in germ cells as human sperm. Using sperm, the oestrogens can cause DNA damage which can be diminished with antioxidants suggesting an oxygen radical involvement. Also as age increases in men so there is an increase in DNA damage. The comet assay can be modified and used as an innovative blood test to predict cancer. From a regulatory viewpoint, the assay is regarded as an indicator test but is incorporated into guidelines in some countries.

Biography :

Diana Anderson has completed her PhD at the University of Manchester, UK in the Faculty of Medicine. She is the Established Chair in Biomedical Sciences at the University of Bradford. She has published more than 450 papers, 8 books and successfully supervised 30 PhD students, she has Hirsch factor of 51. She is the Editor-in-Chief of a Book Series for the Royal Society of Chemistry and Consultant to many international organizations such as the World Health Organization/ International Program of Chemical Safety. She is/has been Member of the Editorial Board of ten international journals.

Email: D.Anderson1@bradford.ac.uk

Top